English
Home > Products > Orlistat API

China Orlistat API Factory

We not only will try our greatest to supply outstanding services to every shopper, but also are ready to receive any suggestion offered by our buyers for Orlistat API,CAS NO 96829-58-2,96829-58-2,Orlistat, We're going to source ideal high quality, by far the most sector competitive rate, for each new and outdated clients while using the most fantastic eco-friendly providers.
Orlistat API, We welcome you to visit our company and factory. It is also convenient to visit our website. Our sales team will present you the best service. If you have to have more information, remember to feel free to contact us by E-mail or telephone. We have been sincerely hope to establish a good long-term business relationship with you through this opportunity, based on equal, mutual benefit from now till the future.

Related Products

Hot Products

  • Clinofibrate

    Clinofibrate

    Product Name:Clinofibrate
    Molecular Formula:C28H36O6
    Molecular Weight;468.58
    CAS Registry Number;30299-08-2
  • N-tert-butyl-L-serineisopropyl ester

    N-tert-butyl-L-serineisopropyl ester

    Product Name:N-tert-butyl-L-serineisopropyl ester
    Molecular Formula:C11H21NO5
    Molecular Weight:247.29
    CAS Registry Number:955379-18-7
  • 1-(CHLOROMETHYL)-2,3,4-TRIFLUOROBENZENE

    1-(CHLOROMETHYL)-2,3,4-TRIFLUOROBENZENE

    Product Name:1-(CHLOROMETHYL)-2,3,4-TRIFLUOROBENZENE
    Molecular Formula:C7H4ClF3
    Molecular Weight:180.55
    CAS Registry Number:292621-60-4
  • Tetrabutylammonium hydrogen sulfate

    Tetrabutylammonium hydrogen sulfate

    Product Name:Tetrabutylammonium hydrogen sulfate
    Molecular Formula:C16H37NO4S
    Molecular Weight:339.53
    CAS Registry Number:32503-27-8
  • 1,2-Diaminocyclohexane

    1,2-Diaminocyclohexane

    Product Name:1,2-Diaminocyclohexane
    Molecular Formula:C6H14N2
    Molecular Weight:114.19
    CAS Registry Number:694-83-7
  • Ramipril

    Ramipril

    Product Name:Ramipril
    Molecular Formula:C23H32N2O5
    Molecular Weight;416.51
    CAS Registry Number;87333-19-5
  • Related Blog
  • Reviews

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept